Key ideas from Noor Siddiqui

• Orchid enables whole genome screening of embryos for thousands of genetic diseases, moving beyond chromosome-level testing to single-letter DNA analysis
• 50% of miscarriages are due to genetic issues in embryos, and over 25% of NICU deaths stem from underlying genetic diseases
• Embryo screening can achieve 30-80% risk reduction for conditions like heart disease, comparable to billion-dollar pharmaceutical interventions
• 80% of Americans support embryo screening according to 2024 nationally representative survey data, with 30% considering IVF for genetic benefits
• South Asians face 4x higher heart disease rates with 25% of heart attacks occurring under age 40, making genetic screening particularly valuable
• Single base pair changes can cause dramatic differences - from 8-foot-3 gigantism to 2-foot-7 achondroplasia conditions
• IVF already creates multiple embryos requiring selection - Orchid provides more information for existing decisions rather than creating new moral questions
• Polygenic risk scores show strongest signals at distribution tails, with 95th+ percentile carrying significantly higher disease risk